TrialMovement disorders : official journal of the Movement Disorder Society2021

Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease.

Fernando L Pagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.